AstraZeneca aims to review bone cancer care with new data across the treatment diapason at SABCS 2022 AstraZeneca will present new data advancing its ambition…
Astellas Announces Zolbetuximab Meets Primary Endpoint in Phase 3 limelight Trial as First- Line Treatment in Claudin18.2 Positive, HER2-Negative Locally Advanced or Metastatic Gastric and…
European Commission approves Enjaymo ®( sutimlimab) for treatment of hemolytic anemia in adult cases with cold agglutinin complaint The European Commission( EC) has granted marketing…
Pfizer and BioNTech Report New Data on OmicronBA.4 Acclimated Bivalent Booster Demonstrating Improved Immune Response Against Arising Omicron Sublineages PfizerInc.( NYSE PFE) and BioNTech SE(…
CHMP Issues Opinion Related to Review of Medicines within the Janus Kinase( JAK) Asset Class AbbVie( NYSE ABBV) blazoned moment the European Medicines Agency’s( EMA)…
Late- Breaking Data from vital Phase 3 PRECISION Study Demonstrates Significant and Sustained Effect of Aprocitentan on Lowering Blood Pressure for Cases with delicate- to-…
AMGEN TO PRESENT NEW exploration ACROSS SERIOUS seditious AND BONE conditions AT ACR 2022New Real- World substantiation Highlights AMGEVITA ® Application, Treatment Satisfaction and continuity…
Keeping the spirit of cricket in mind, Eminence Business Media is proud to announce T10Indian Pharma Champions Trophy 2022 scheduled for December 1st- 7th, 2022,…
Allergan Aesthetics Reaffirms Commitment to bone Health Advocacy with Yearlong Program for bone Cancer mindfulnessPINK strip STRONG 365 IS devoted TO furnishing EDUCATIONAL enterprise AND…
Allergan Aesthetics Celebrates Fourth Annual BOTOX ® Cosmetic( onabotulinumtoxinA) DayAllergan Aesthetics, an AbbVie company( NYSE ABBV), is inviting people across the country to take a”…
New two- time efficacity and safety data for tolebrutinib, Sanofi’s investigational, brain- penetrant and bioactive BTK asset, to be presented at ECTRIMS 2022 New data…
GSK plc( LSE/ NYSE GSK) moment reports that the US Food and Drug Administration( FDA) Cardiovascular and Renal medicines Advisory Committee( CRDAC) supported that the…